Tag: Tricuspid Valve

SHDA Research Update – July 2017

Welcome to the monthly SHDA Research Update. Our specialists have selected 3 seminal papers that have been recently published in each speciality (Cardiology, Cardiac Surgery, Cardiac Imaging, Perioperative Medicine). Cardiology Summarised by Sarah Catchpoole  Lytwyn J, et al. The impact of frailty on functional survival in patients 1 year after cardiac surgery. J Thorac Cardiovasc Surg. 2017 Jun 24. The prognostic value of three fraility indices were compared with the European System for Cardiac Operative Risk Evaluation II (euroSCORE II) in this prospective cohort of 188 patients (median age 71) undergoing elective (n=155) or urgent cardiac surgery (n=33). Prevalence of frailty was...

Read More

SHDA Research Update – May 2017

Welcome to the monthly SHDA Research Update. Our specialists have selected 3 seminal papers that have been recently published in each speciality (Cardiology, Cardiac Surgery, Cardiac Imaging, Perioperative Medicine). Cardiology Summarised by Sarah Catchpoole Regueiro A, et al. Transcatheter Mitral Valve Replacement: Insights From Early Clinical Experience and Future Challenges. J Am Coll Cardiol. 2017 May 2.  While transcatheter mitral valve repair has become established practice, less is known about transcatheter mitral valve replacement (TMVR). This review summarises the development, challenges, and future potential of TMVR, as well as the devices currently in pre-clinical or clinical evaluation. Results from early clinical trials involving 115...

Read More

SHDA Research Update – April 2017

Welcome to the monthly SHDA Research Update. Our specialists have selected 3 seminal papers that have been recently published in each speciality (perioperative medicine, cardiac imaging, cardiology, cardiothoracic surgery). Cardiology Summarised by Sarah Catchpoole        Hahn et al. Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty. J Am Coll Cardiol. 2017 Apr 11. Transcatheter interventions for tricuspid valve disease of growing interest. This paper describes the 30 day results of the SCOUT trial, the first early feasibility study of a novel device (TriAlign®) for tricuspid regurgitation (TR). Device implantation was achieved without complications in all 15 enrolled patients across four centres, with...

Read More

Recent Tweets

Subscribe